Last Updated 24 January 2022.
6 Vaccines Approved for Use in Kazakhstan
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 136 countries
58 trials in 24 countries
Approval Source: astanatimes.com
-
Gamaleya
Sputnik Light- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 24 countries
4 trials in 2 countries
Approval Source: reuters.com
-
Gamaleya
Sputnik V- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 74 countries
22 trials in 7 countries
Approval Source: tass.com
-
Kazakhstan RIBSP
QazVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
Approval Source: reuters.com
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
22 trials in 11 countries
Approval Source: astanatimes.com
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 52 countries
29 trials in 9 countries
Approval Source: astanatimes.com
2 Vaccines in Clinical Trials in Kazakhstan
-
Kazakhstan RIBSP
QazVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 2 countries
3 trials in 1 country
-
Research Institute for Biological Safety Problems
QazCoVac-P- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine has reached Phase 2 trials.
2 trials in 1 country